Recent advances in diagnostic tools have revolutionized Lymphoma the field of lymphoma treatment. Among this progress, liquid biopsy has emerged as a promising methodology for detecting minimal residual disease (MRD). Unlike traditional biopsies that demand tissue sampling, liquid biopsies analyze c

Minimal residual disease (MRD) identification is crucial in lymphoma management as it predicts relapse risk and guides therapeutic decisions. Traditional MRD methods often involve invasive biopsies, leading to patient discomfort and potential complications. Liquid biopsy, a non-invasive technique an

Minimal residual disease (MRD) detection is crucial in lymphoma management as it predicts relapse risk and guides therapeutic decisions. Traditional MRD methods often involve invasive biopsies, leading get more info to patient discomfort and potential complications. Liquid biopsy, a non-invasive tec

Liquid biopsy has emerged as a innovative method for detecting minimal residual disease (MRD) in lymphoma. Unlike traditional tissue biopsies, which are invasive, liquid biopsy analyzes cell-free DNA present in bodily fluids such as serum. This gentle procedure allows for continuous monitoring of MR